Virgin Islands from 2008 to 2011.

Kaiser Family Foundation. Kaiser Health Information, an editorially independent information service, is an application of the Kaiser Family members Foundation, a nonpartisan health care policy research firm unaffiliated with Kaiser Permanente., a kept biopharma company privately, announced today that they have entered into an agreement to develop and commercialize Chiasma's proprietary item Octreolin, for acromegaly and subsequently for neuroendocrine tumors initially. Octreolin is an investigational oral type of the peptide octreotide, a somatostatin analog that is available only by injection commercially. Genentech will market the merchandise in the United States after US FDA acceptance.That's a Tuscaloosa-based cosmetic surgeon's theory likely headed for a clinical trial early next calendar year and 1 drawing support from a University of Alabama researcher who studies how viruses replicate. The idea of Dr. William Skip Pridgen, the physician, is now at the core of a start-up organization, Innovative Med Ideas, which has already raised most of the capital needed to fund the Stage II clinical trial to test a novel pain-treatment therapy. Pridgen may be the ongoing company;s president and managing partner. Dr. Carol Duffy, a UA associate professor of biological sciences, serves while the ongoing company;s chief scientific adviser.

Related Posts

Other Posts From Category "cosmetic surgery":